Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Cash & Equivalents (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Cash & Equivalents of $144.9 million for Q1 2026, up 2397.81% year-over-year from $5.8 million in Q1 2025, and up 2823.77% quarter-over-quarter from $5.0 million in Q4 2025.

Scilex Holding (SCLX) Cash & Equivalents (2020 - 2026) Analysis & Trends

Scilex Holding's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $144.9 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 2397.81% year-over-year to $144.9 million; the TTM figure through Mar 2026 stood at $144.9 million (up 2397.81% YoY), while the FY2025 annual figure was $5.0 million, up 51.44% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $144.9 million, up from $5.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $144.9 million in Q1 2026, with the low at $34961.0 in Q3 2022.
  • The 5-year median for Cash & Equivalents is $3.3 million (2024), against an average of $13.0 million.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 9607.58% in 2023, then plunged 96.06% in 2024.
  • Scilex Holding's Cash & Equivalents stood at $2.2 million in 2022, then jumped by 79.53% to $3.9 million in 2023, then slipped by 16.55% to $3.3 million in 2024, then surged by 51.44% to $5.0 million in 2025, then surged by 2823.77% to $144.9 million in 2026.
  • Business Quant data shows SCLX's Cash & Equivalents at $144.9 million in Q1 2026, $5.0 million in Q4 2025, and $900000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 20.42 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 6.57 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 4.90 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 3.18 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 976.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 4.17 Bn
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn 112.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 144.87 Mn
Dec 31, 2025 4.96 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.80 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 77,000.00
Jun 30, 2024 6.89 Mn
Mar 31, 2024 1.80 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 1.95 Mn
Jun 30, 2023 34.10 Mn
Mar 31, 2023 5.10 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 34,961.00
Jun 30, 2022 351,272.00
Mar 31, 2022 250,000.00
Dec 31, 2021 4.34 Mn
Sep 30, 2021 115,642.00
Jun 30, 2021 257,621.00